Genital Gender Affirming Surgery for the Transgender Patient: A Didactic and Hands-on Fresh Cadaver-Based Course (2018)
This is a one-day course comprised of didactic lectures and two 2-hour hands-on fresh-cadaver labs covering both adult male-to-female and female-to-male common genital gender affirming surgeries (GAS). This course is designed for the general urologist, but also offers substantial learning opportunities for the practicing gender surgeon. The course will be taught by leading clinical urology faculty from the U.S. and U.K. In addition, anatomists from the UCSF Department of Anatomy will also participate in teaching the cadaver-based lab portion of the course.
The didactic lectures will cover an introduction to the adult patient population, review of transgender epidemiologic data, review of culturally-competent terminology, review of current transgender care guidelines and what requirements patients must meet to qualify for genital GAS. Additional topics include a review of the medical specialties that routinely participate in adult transgender care and a review of both adult male-to-female (MtoF) and adult female-to-male (FtoM) genital gender affirming surgeries. Following the hands-on sessions, experts will discuss common post-op hospital pathways for both adult MtoF and FtoM genital gender affirming surgeries, common complications, the design and make-up of a balanced gender affirming surgery program, what surgical instruments the general urologist and practicing gender surgeon may find useful in daily practice and commonly used ICD diagnostic and CPT procedure codes. Throughout the course, attendees will have the opportunity to ask questions of all of the faculty.
Hands-on lab sessions will cover the surgical steps and anatomic basis for both adult MtoF and FtoM genital gender affirming surgeries. Fresh human cadavers in various states of prosection will be presented. Surgical techniques, important surgical landmarks and clinical pitfalls will be reviewed. Each participant will be provided with their own individual iPad loaded with a review of the entire lab and live surgery videos.
This activity is designed for:
- Recontructive Urologists
After completing this activity, participants will be able to:
- Use terminology related to the adult patient population and their care and appraise epidemiologic data about transgender people in the U.S.
- Describe the related preparations adult transgender patients in the process of transition must complete before being ready to undergo genital gender affirming surgery (GAS).
- Outline the principal surgical steps in FtoM genital surgery with metoidioplasty and phallo-urethroplasty and explain state how these can be staged.
- Outline the principal surgical steps in MtoF genital surgery with vaginoplasty with and without creation of a neovagina and explain how these can be staged.
- Describe important anatomic landmarks and key surgical steps for (MtoF) vaginoplasty and (FtoM) phallo-urethroplasty surgeries.
- Identify what surgical instruments, dressings, and durable medical goods are most useful with genital GAS.
- Describe common genital GAS post-operative care pathways.
- Review common surgical complications and their management.
- Discuss common challenges patients face during recovery after surgery.
Accreditation: The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation: The American Urological Association designates this live activity for a maximum of 7.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other Learners: The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.
Evidence Based Content: It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.
AUA Disclosure Policy: All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.
Resolution of Identified Conflict of Interest: All disclosures will be reviewed by the program/course directors or editors for identification of conflicts of interest. Peer reviewers, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:
- Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or Education Content Review Committee or its subgroup.
- Limit content to evidence with no recommendations
- Introduction of a debate format with an unbiased moderator (point-counterpoint)
- Inclusion of moderated panel discussion
- Publication of a parallel or rebuttal article for an article that is felt to be biased
- Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
- Divestiture of the relationship by faculty
Off-label or Unapproved Use of Drugs or Devices: The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.
- 7.00 AMA PRA Category 1 Credit™
- 7.00 Non-Physician Participation